Application of Desferal to Treat COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
In this study, defined cases of COVID-19 with mild, moderate or severe pneumonia will be treated with standard treatment regimens in combination with IV injection of Deferoxamine. Improvement in clinical, laboratory and radiological manifestations will be evaluated in treated patient compared to control group.
Epistemonikos ID: ae4fb3215af940748631118cc84860490c9df787
First added on: Apr 06, 2020